Sam Bankman-Fried’s defence team has raised concerns about their client’s ability to effectively testify in his fraud trial without access to his prescribed ADHD medication, Adderall. In a court filing dated October 15, Bankman-Fried’s legal representatives requested accommodations from Judge Lewis A. Kaplan, seeking approval for Bankman-Fried to take his prescribed dose of Adderall during trial hours. The defence argues that Bankman-Fried’s inability to access the medication has hindered his concentration and ability to participate meaningfully in his defence.
The defence claims that attempts to resolve the issue with the Bureau of Prisons (BOP) have gone unanswered, prompting the urgent request for a solution. Bankman-Fried’s legal team proposes a compromise where he would be allowed to take his prescribed Adderall at the courthouse on trial days. They have also requested a one-day adjournment on October 17 to resolve the medication matter and provide additional time for trial preparation.
This development adds a new layer of complexity to a trial already filled with intrigue. The government’s case against Bankman-Fried revolves around allegations of fraud and conspiracy, accusing him of stealing from customers, defrauding investors, and concealing these actions. The prosecution’s star witness, Caroline Ellison, former CEO of Alameda Research and romantically involved with Bankman-Fried, has provided compelling testimonies that shed light on the alleged wrongdoing.
Ellison’s testimony revealed financial documents she prepared, which she labeled as dishonest and designed to hide Alameda’s shaky financial situation. She also disclosed that Alameda had a secret line of credit to access FTX customer funds without their knowledge or consent. Ellison’s emotional accounts and insights into Bankman-Fried’s calculated public image have painted him as the central figure in critical decisions at Alameda and FTX.
The defence faced a challenging cross-examination of Caroline Ellison, lasting approximately six hours, marked by objections from the prosecution and moments of exasperation from Judge Lewis Kaplan. Bankman-Fried’s defence team is now urgently seeking a resolution to the medication issue to ensure their client can actively participate in his defence.